Zura Bio (ZURA) Research & Development (2022 - 2026)
Zura Bio (ZURA) posted quarterly Research & Development of $14.7 million for Q1 2026, up 40.79% year-over-year from $10.5 million in Q1 2025, and up 34.59% quarter-over-quarter from $11.0 million in Q4 2025.
Zura Bio (ZURA) Research & Development (2022 - 2026) Analysis & Trends
Zura Bio's Research & Development history runs 5 years deep, the most recent figure standing at $14.7 million for Q1 2026.
- In Q1 2026, Research & Development rose 40.79% year-over-year to $14.7 million; the TTM figure through Mar 2026 stood at $46.4 million (up 48.18% YoY), while the FY2025 annual figure was $42.1 million, up 72.46% from the prior year.
- Research & Development for Q1 2026 stood at $14.7 million, up from $11.0 million in the prior quarter.
- The five-year high for Research & Development was $28.2 million in Q2 2023, with the low at $85000.0 in Q2 2022.
- The 5-year median for Research & Development is $7.5 million (2022), against an average of $8.8 million.
- The sharpest annual moves came in 2023 and 2024: Research & Development surged 33111.76% in 2023, then sank 80.38% in 2024.
- Zura Bio's Research & Development stood at $15.7 million in 2022, then slumped by 55.89% to $6.9 million in 2023, then jumped by 33.53% to $9.2 million in 2024, then gained by 18.57% to $11.0 million in 2025, then soared by 34.59% to $14.7 million in 2026.
- Business Quant data shows ZURA's Research & Development at $14.7 million in Q1 2026, $11.0 million in Q4 2025, and $11.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.37 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 394.92 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 612.28 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1,146.05 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 97.90 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 413.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Zura Bio | 706.30 Mn | 706.30 Mn | - | 20.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.71 Mn |
| Mar 31, 2026 | 14.75 Mn |
| Dec 31, 2025 | 10.96 Mn |
| Sep 30, 2025 | 11.95 Mn |
| Jun 30, 2025 | 8.70 Mn |
| Mar 31, 2025 | 10.47 Mn |
| Dec 31, 2024 | 9.24 Mn |
| Sep 30, 2024 | 6.03 Mn |
| Jun 30, 2024 | 5.54 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 6.92 Mn |
| Sep 30, 2023 | 3.97 Mn |
| Jun 30, 2023 | 28.23 Mn |
| Mar 31, 2023 | 4.88 Mn |
| Dec 31, 2022 | 15.69 Mn |
| Sep 30, 2022 | 415,000.00 |
| Jun 30, 2022 | 85,000.00 |
| Mar 31, 2022 | 7.50 Mn |